bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate has been researched along with Insulin Sensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deshaies, Y; Labrie, F; Lemieux, C; Picard, F; Richard, D | 1 |
| Bélanger, A; Deshaies, Y; Labrie, C; Labrie, F; Lalonde, J; Picard, F; Richard, D; Samson, P | 1 |
2 other study(ies) available for bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate and Insulin Sensitivity
| Article | Year |
|---|---|
The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Cholesterol; Dehydroepiandrosterone; Diet; Dietary Fats; Dietary Sucrose; Eating; Energy Intake; Energy Metabolism; Estrogen Antagonists; Female; Insulin Resistance; Lipoprotein Lipase; Liver; Obesity; Ovariectomy; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides; Weight Gain | 2003 |
Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats.
Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Energy Metabolism; Estrogen Antagonists; Female; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Obesity; Ovariectomy; Piperidines; Rats; Rats, Sprague-Dawley; Risk Factors; Selective Estrogen Receptor Modulators | 2000 |